Annovis Bio ANVS
Annovis Bio, Inc. will conduct a webinar.
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001104659-26-007423
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Abvc Biopharma ABVC public float $37M, Jun 30, 2025
- Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
- Grace Therapeutics GRCE public float $35M, Sep 30, 2025
- BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
- Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025